Prevention of bone metastases in breast cancer
The paper deals with the prevention of bone metastases in patients with breast cancer (BC). The drugs from a group of bisphosphonates are ascertained to play an important role in combination therapy for bone metastases. Bonefos (clodronate) is one of these agents used in BC patients for prophylaxis.
Saved in:
Main Author: | L. M. Kogonia (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2014-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases
by: A. S. Kolbin, et al.
Published: (2018) -
Current approaches to therapy for complications of bone metastases from breast cancer
by: L. G. Zhukova
Published: (2014) -
Time course of changes in bone resorption markers during pamidronate therapy in breast cancer patients with bone metastases
by: A. D. Petrova, et al.
Published: (2014) -
Machine learning predicts the prognosis of breast cancer patients with initial bone metastases
by: Chaofan Li, et al.
Published: (2022) -
Scalp metastases in breast cancer
by: A. N. Mareeva, et al.
Published: (2019)